Clinical trial Recruiting at 1 site Observational Ages 18 and up

Observational study on cluster headaches and trigeminal neuralgia

Official title: The Will Erwin Headache Research Center Study of Cluster Headache and Trigeminal Neuralgia

Run by The University of Texas Health Science Center, Houston · NCT02910323 · Data updated 2026-11-12

This study is trying to learn more about cluster headaches and trigeminal neuralgia by gathering information from patients to help match them for future treatments.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment1500 (estimated)
SponsorThe University of Texas Health Science Center, Houston
Academic / other
Locations1 site (Houston, Texas)
StatusRecruiting
StartedJuly 12, 2016
Main results expectedDecember 2035
Study endsDecember 2035
Registry record updatedFebruary 18, 2026
Trial IDNCT02910323 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals diagnosed with trigeminal autonomic cephalalgias or trigeminal neuralgia as per the International Headache Classification.

Probably not a fit

Patients with a life expectancy of less than one year or those with conditions that hinder appropriate diagnosis will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Will Erwin Headache Research Center is creating a national registry for patients with Cluster Headache and Trigeminal Neuralgia. This observational study will categorize participants based on various characteristics such as type and severity of their condition, associated symptoms, and psychological factors. Detailed evaluations will include genomic studies, medical history, imaging reports, and physical exams. The goal is to better understand these conditions and facilitate patient matching for future interventional clinical trials.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and management of cluster headaches and trigeminal neuralgia.

How similar studies have gone: Other studies have shown promise in understanding trigeminal autonomic cephalalgias, but this specific observational approach is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of a trigeminal autonomic cephalalgia according to the International Headache Classification including episodic cluster headache, chronic cluster headache, episodic paroxysmal hemicrania, chronic paroxysmal hemicrania, episodic short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT), chronic SUNCT, episodic short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms (SUNA), chronic SUNA, and hemicrania continua. OR Diagnosis of a trigeminal neuralgia according to the International Headache Classification, including classical trigeminal neuralgia and symptomatic trigeminal neuralgia.
* Able to provide HIPAA authorization to share prior medical records/imaging.

Exclusion Criteria:

* Life expectancy less than 1 year, co-existing disease or other characteristic that precludes appropriate diagnosis of a trigeminal autonomic cephalalgia or trigeminal neuralgia.
* Active drug or alcohol use or dependence that, in the opinion of the site investigator, would interfere with adherence to study requirements
* Inability or unwillingness of subject or legal guardian/representative to give informed consent.

Inclusion Criteria for Healthy Volunteers:

* Inclusion criteria is willingness to consent and be of age 18 and older

Where it's running

  • The University of Texas Health Science Center at Houston
    Houston, Texas, United States
    Recruiting

Study contacts

  • Principal investigator: Mark Burish, MD, PhD — The University of Texas Health Science Center, Houston
  • Study coordinator: Rebecca Martinez, RN
  • Email: nctt.wec@uth.tmc.edu
  • Phone: 713-486-7771

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.